| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/14/2009 | CA2704859A1 Topical treatment with dapsone in g6pd-deficient patients |
| 05/14/2009 | CA2704663A1 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/14/2009 | CA2704380A1 Avenanthramide-containing compositions |
| 05/14/2009 | CA2703705A1 Methods of treating scleroderma |
| 05/13/2009 | EP2058332A1 Use of CD25 binding molecules in steroid-resistant patients |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058309A1 Fused heterocyclic compound |
| 05/13/2009 | EP2057988A1 Nail patch |
| 05/13/2009 | EP2057987A1 Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 05/13/2009 | EP2057165A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 05/13/2009 | EP2057124A2 Compounds and compositions as itpkb inhibitors |
| 05/13/2009 | EP2056855A1 Method of treatment of photodermatoses |
| 05/13/2009 | EP2056854A1 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 05/13/2009 | EP2056843A2 Use of c7 sugars in prevention and treatment of mycoses |
| 05/13/2009 | EP2056833A2 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 05/13/2009 | EP2056815A1 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis |
| 05/13/2009 | EP2056814A1 2,5-dihydroxybenzene compounds for the treatment of psoriasis |
| 05/13/2009 | EP2056813A1 2,5 dihydroxybenzene compounds for the treatment of rosacea |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP1753712B1 Amino-propanol derivatives |
| 05/13/2009 | EP1483373B1 Surgical device for skin therapy or testing |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1178818A4 A stable composition comprising epidermal growth factor as an active ingredient |
| 05/13/2009 | CN101432009A Preventative treatment and remission of allergic diseases |
| 05/13/2009 | CN101431997A Melatonin and immunostimulating substance-based compositions |
| 05/13/2009 | CN101431980A Fermented product composition, cosmetic composition and method of producing the same |
| 05/13/2009 | CN101428135A Micro-element reinforced externally used liniment |
| 05/13/2009 | CN101428122A Traditional Chinese medicine powder for removing necrosis and promoting granulation, and preparation method thereof |
| 05/13/2009 | CN101428118A Externally used traditional Chinese medicine for treating scaly tetter |
| 05/13/2009 | CN101428116A Shengjinsan |
| 05/13/2009 | CN101428112A Formulation for treating acne and preparation method thereof |
| 05/13/2009 | CN101428098A Medicament for treating leukoderma |
| 05/13/2009 | CN101428097A Psoriasis treating Chinese medicine preparation and its preparing process |
| 05/13/2009 | CN101428087A Method of preparing plaster for quickly curing ulcer between toes |
| 05/13/2009 | CN101428082A Medical ointment for treating empyrosis |
| 05/13/2009 | CN101428076A Process for producing cassia twig tuckahoe formulation |
| 05/13/2009 | CN101428061A Medicament for treating psoriasis, skin stubborn dermatitis |
| 05/13/2009 | CN101428060A Traditional Chinese medicine preparation for treating leuoderma |
| 05/13/2009 | CN101428058A Liniment for treating leukoderma |
| 05/13/2009 | CN101428046A Novel broad spectrum antiphlogistic pain-easing externally used medicament |
| 05/13/2009 | CN101428042A Guereza recovery plaster |
| 05/13/2009 | CN101428040A Tigason powder |
| 05/13/2009 | CN101428038A Powder preparation for quick cicatrization of incised wound |
| 05/13/2009 | CN101427988A Moisture paper tissue containing hamamelidaceae plant extract liposome |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486990C Glutathione calcium chelate and its preparing method, use and composition |
| 05/13/2009 | CN100486633C External use Chinese medicine for treating burn and scold and its preparing method |
| 05/13/2009 | CN100486622C Medicated pad |
| 05/13/2009 | CN100486611C Health-care foot-soaking liquid for diabetes and its preparation |
| 05/13/2009 | CN100486584C Application of amygdalin in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 05/13/2009 | CN100486582C Liniment for treating flat wart |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531510 Methods of recruiting fibroblasts by administering G-CSF |
| 05/12/2009 | US7531347 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | CA2478237C Use of adapalene for the treatment of dermatological disorders |
| 05/12/2009 | CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/07/2009 | WO2009059032A2 Uses and isolation of very small embryonic-like (vsel) stem cells |
| 05/07/2009 | WO2009058361A1 Inhibition of type i ifn production |
| 05/07/2009 | WO2009057836A1 Use of melanin biosynthesis inhibitors from korean ginseng and the cosmetic composition containing thereof for skin whitening |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009057456A1 Gel sheet and cosmetic preparation in sheet form using the same |
| 05/07/2009 | WO2009056952A1 Geminal bisphosphonates, their preparation and their use in the field of oncology |
| 05/07/2009 | WO2009056754A2 Use of econazole or salts thereof for treating acne |
| 05/07/2009 | WO2009055934A1 Treatment of fibrillinopathy or elastinopathy using granzyme inhibitors |
| 05/07/2009 | WO2009055857A1 Calcium-rich alkaline powder produced from processed molluse shells |
| 05/07/2009 | WO2007067364A3 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 05/07/2009 | WO2007055760A3 Protein composition for promoting wound healing and skin regeneration |
| 05/07/2009 | US20090118378 Technical information for a formula of a natural facial moisturizing cream for daytime use which contains a propylene glycol extract of plant specie solanum tuberosum |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118324 Mapk/erk kinase inhibitors |
| 05/07/2009 | US20090118302 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118266 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/07/2009 | US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 05/07/2009 | US20090118244 Benzodiazepinone compounds useful in the treatment of skin conditions |
| 05/07/2009 | US20090118228 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117174 Modified sorbitan siloxane compositions and use thereof |
| 05/07/2009 | US20090117146 System and method for promoting hair growth and improving hair and scalp health |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117064 Stable vitamin b6 derivative |
| 05/07/2009 | DE102007052536A1 Wirkstoffkombinationen aus Anisfruchtextrakt und Weißen Teeextrakt Active compound combinations of anise fruit and white tea extract |
| 05/07/2009 | DE10010113B4 Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung Native collagen sponge, process for its isolation and its use, as well as native nanoparticulate sponge collagen, process for its preparation and its use |